Search Results
Elaine Husni, MD, MPH: Rheumatologists' Comfort With Biosimilars
Elaine Husni, MD: Rheumatologists Attitudes Toward Biosimilars
Dr Elaine Husni: Huge Savings With Biosimilars Have Not Manifested
Elaine Husni, MD, MPH: Biosimilars and Cost Savings for Patients
Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni
CAPES: Does Changing Health Behaviors Help Your Arthritis? Lifestyle, Myths, and Solutions
Leveraging Digital Tech and Shared Decision-Making in PsA Care - Medpage Today
How are biosimilars going to affect patients with rheumatic diseases?
Exploring the Potential of Guselkumab in Psoriatic Arthritis - Medpage Today
Olokizumab: What makes it an effective and novel treatment for RA? | Roy Fleischmann
The practicality of prescribing and administering biosimilars
New report sheds light on the pain arthritis patients live with every day